We just received data on a new analyst forecast for $PAYX. Bryan Bergin from TD Cowen set a price target of 114.0 for PAYX.
To track analyst ratings and price targets for $PAYX, check out Quiver Quantitative's $PAYX forecast page.
Should you buy $PAYX?
Some analysts are better than others. To view the past performance of TD Cowen, check out Quiver’s Analyst Ratings dashboard. You can also see Quiver’s Analyst Buys Strategy, which uses a proprietary method to track the companies being recommended by the top Wall Street analysts.
$PAYX Price Targets
Multiple analysts have issued price targets for $PAYX recently. We have seen 10 analysts offer price targets for $PAYX in the last 6 months, with a median target of $140.0.
Here are some recent targets:
- Bryan Bergin from TD Cowen set a target price of $114.0 on 12/01/2025
- Jason Kupferberg from Wells Fargo set a target price of $128.0 on 10/22/2025
- James Faucette from Morgan Stanley set a target price of $133.0 on 10/20/2025
- Charles Nabhan from Stephens & Co. set a target price of $135.0 on 10/07/2025
- Daniel Jester from BMO Capital set a target price of $140.0 on 10/01/2025
- David Grossman from Stifel set a target price of $142.0 on 09/22/2025
- Kevin Mcveigh from UBS set a target price of $140.0 on 09/17/2025
$PAYX Congressional Stock Trading
Members of Congress have traded $PAYX stock 7 times in the past 6 months. Of those trades, 4 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $PAYX stock by members of Congress over the last 6 months:
- REPRESENTATIVE MARJORIE TAYLOR GREENE purchased up to $50,000 on 11/12.
- SENATOR SHELLEY MOORE CAPITO sold up to $15,000 on 10/21.
- REPRESENTATIVE APRIL MCCLAIN DELANEY has traded it 2 times. They made 2 purchases worth up to $30,000 on 10/01, 06/26 and 0 sales.
- REPRESENTATIVE JULIE JOHNSON sold up to $15,000 on 09/25.
- REPRESENTATIVE LISA C. MCCLAIN has traded it 2 times. They made 1 purchase worth up to $15,000 on 07/16 and 1 sale worth up to $15,000 on 08/04.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$PAYX Insider Trading Activity
$PAYX insiders have traded $PAYX stock on the open market 4 times in the past 6 months. Of those trades, 0 have been purchases and 4 have been sales.
Here’s a breakdown of recent trading of $PAYX stock by insiders over the last 6 months:
- MARTIN MUCCI sold 97,526 shares for an estimated $14,157,849
- JOHN B GIBSON (President and CEO) sold 12,370 shares for an estimated $1,755,550
- ROBERT L. SCHRADER (Sr. VP, CFO) sold 3,160 shares for an estimated $444,390
- CHRISTOPHER C SIMMONS (VP, Controller & Treasurer) sold 1,843 shares for an estimated $259,826
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$PAYX Hedge Fund Activity
We have seen 651 institutional investors add shares of $PAYX stock to their portfolio, and 923 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- VANGUARD GROUP INC added 5,549,511 shares (+17.2%) to their portfolio in Q3 2025, for an estimated $703,456,014
- CAPITAL INTERNATIONAL INVESTORS removed 3,492,299 shares (-15.5%) from their portfolio in Q3 2025, for an estimated $442,683,821
- BANK OF NEW YORK MELLON CORP removed 3,108,354 shares (-35.8%) from their portfolio in Q3 2025, for an estimated $394,014,953
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 1,659,894 shares (+43.6%) to their portfolio in Q3 2025, for an estimated $210,408,163
- NORGES BANK added 1,520,047 shares (+272.5%) to their portfolio in Q2 2025, for an estimated $221,106,036
- WORLDQUANT MILLENNIUM ADVISORS LLC added 1,297,150 shares (+inf%) to their portfolio in Q3 2025, for an estimated $164,426,734
- CAPITAL WORLD INVESTORS removed 1,050,014 shares (-70.5%) from their portfolio in Q3 2025, for an estimated $133,099,774
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
